← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 15, 2017Last known activity
Oct 31, 2024
Timeline
2010s
- Jun 1, 2017
Tvardi Therapeutics, Incorporated— Founded
Drugs by trial phase (5 distinct, 7 trials)
Phase 2 (5 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT05845307CollaboratorEarly Phase 1Oct 31, 2024
- NCT06141031CollaboratorPhase 1/Phase 2Dec 31, 2023
- NCT05668949CollaboratorPhase 1/Phase 2Jun 30, 2023
- NCT05671835Lead sponsorPhase 2May 15, 2023
- NCT05440708Lead sponsorPhase 1/Phase 2Nov 30, 2022
- NCT05384119Lead sponsorPhase 1/Phase 2Nov 30, 2022
- NCT03195699Lead sponsorPhase 1Nov 15, 2017
Details
- Founded
- Houston, TX, US Jun 1, 2017
- Last known activity
- Oct 31, 2024